Buy Myrbetriq 25 mg/1 mirabegron

Myrbetriq 25 mg is an extended-release tablet used to treat overactive bladder symptoms. This medication helps manage urinary urgency, frequency, and incontinence. Myrbetriq contains mirabegron, a selective beta-3 adrenergic agonist.

Strength

25 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0469-2601-30) / 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE

Manufacturer / TM Owner

Astellas Pharma US, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Myrbetriq 25 mg is primarily used for the treatment of overactive bladder (OAB) symptoms. This includes reducing urinary urgency, frequency, and episodes of urge incontinence. The active ingredient, mirabegron, works by relaxing the bladder muscle, which can help increase bladder capacity and reduce symptoms. People often ask, 'What is Myrbetriq used for?' and the answer is that it is designed to improve bladder control and reduce the discomfort associated with OAB.

Side Effects

Common effects of Myrbetriq 25 mg may include increased blood pressure, dry mouth, and constipation. Some users might experience headaches or dizziness. These effects can vary from person to person, and not everyone will experience them. It's important to monitor any changes in your health while taking this medication.

Precautions & Warnings

Myrbetriq 25 mg should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by your healthcare professional. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Myrbetriq 25 mg may interact with certain medications, including those metabolized by the liver's CYP2D6 enzyme. It is also important to avoid taking this medication with strong CYP3A4 inhibitors. Additionally, alcohol consumption should be limited as it may exacerbate some side effects. Always consult your healthcare provider before starting any new medication.

References

Frequently Asked Questions

Myrbetriq is used to treat symptoms of overactive bladder, such as urinary urgency, frequency, and incontinence.

Myrbetriq 25 mg should be taken orally, typically once daily, with or without food. Follow your healthcare provider's instructions for the best results.

Common side effects may include increased blood pressure, dry mouth, constipation, headaches, and dizziness.

It is advisable to limit alcohol consumption while taking Myrbetriq, as it may worsen some side effects.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.